AAAAAA

   
Results: 1-13 |
Results: 13
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
Authors: Grimwade, D
Citation: D. Grimwade, The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia, BEST P R C, 14(3), 2001, pp. 497-529
Variability in the levels of PML-RAR alpha fusion transcripts detected by laboratories participating in an external quality control program using several reverse transcription polymerase chain reaction protocols
Authors: Bolufer, P Lo Coco, F Grimwade, D Barragan, E Diverio, D Cassinat, B Chomienne, C Gonzalez, M Colomer, D Gomez, MT Marugan, I Roman, J Delgado, MD Garcia-Marco, JA Bornstein, R Vizmanos, JL Martinez, B Jansen, J Villegas, A de Blas, JM Cabello, P Sanz, MA
Citation: P. Bolufer et al., Variability in the levels of PML-RAR alpha fusion transcripts detected by laboratories participating in an external quality control program using several reverse transcription polymerase chain reaction protocols, HAEMATOLOG, 86(6), 2001, pp. 570-576
Testicular relapse in acute promyelocytic leukaemia
Authors: New, HV Dogan, A Patterson, K Grimwade, D
Citation: Hv. New et al., Testicular relapse in acute promyelocytic leukaemia, BR J HAEM, 112(2), 2001, pp. 258-258
EVI1 expression in acute myeloid leukaemia
Authors: Langabeer, SE Rogers, JR Harrison, G Wheatley, K Walker, H Bain, BJ Burnett, AK Goldstone, AH Linch, DC Grimwade, D
Citation: Se. Langabeer et al., EVI1 expression in acute myeloid leukaemia, BR J HAEM, 112(1), 2001, pp. 208-211
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial
Authors: Grimwade, D Walker, H Harrison, G Oliver, F Chatters, S Harrison, CJ Wheatley, K Burnett, AK Goldstone, AH
Citation: D. Grimwade et al., The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial, BLOOD, 98(5), 2001, pp. 1312-1320
Repression of CD2 gene expression is mediated by an AP-2 related factor
Authors: Outram, SV Grimwade, D Crompton, T
Citation: Sv. Outram et al., Repression of CD2 gene expression is mediated by an AP-2 related factor, BIOC BIOP R, 281(2), 2001, pp. 409-415
Identification of PML/RAR alpha rearrangements in suspected acute promyelocytic leukemia using fluorescence in situ hybridization of bone marrow smears: a comparison with cytogenetics and RT-PCR in MRC ATRA trial patients
Authors: Iqbal, S Grimwade, D Chase, A Goldstone, A Burnett, A Goldman, JM Swirsky, D
Citation: S. Iqbal et al., Identification of PML/RAR alpha rearrangements in suspected acute promyelocytic leukemia using fluorescence in situ hybridization of bone marrow smears: a comparison with cytogenetics and RT-PCR in MRC ATRA trial patients, LEUKEMIA, 14(5), 2000, pp. 950-953
Screening for mutations of Bcl10 in leukaemia
Authors: Grimwade, D Du, MQ Langabeer, S Rogers, J Solomon, E
Citation: D. Grimwade et al., Screening for mutations of Bcl10 in leukaemia, BR J HAEM, 109(3), 2000, pp. 611-615
A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements
Authors: Sainty, D Liso, V Cantu-Rajnoldi, A Head, D Mozziconacci, MJ Arnoulet, C Benattar, L Fenu, S Mancini, M Duchayne, E Mahon, FX Gutierrez, N Birg, F Biondi, A Grimwade, D Lafage-Pochitaloff, M Hagemeijer, A Flandrin, G
Citation: D. Sainty et al., A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements, BLOOD, 96(4), 2000, pp. 1287-1296
Characterization of acute promyelocytic leukemia cases lacking the classict(15;17): results of the European Working Party
Authors: Grimwade, D Biondi, A Mozziconacci, MJ Hagemeijer, A Berger, R Neat, M Howe, K Dastugue, N Jansen, J Radford-Weiss, I Lo Coco, F Lessard, M Hernandez, JM Delabesse, E Head, D Liso, V Sainty, D Flandrin, G Solomon, E Birg, F Lafage-Pochitaloff, M
Citation: D. Grimwade et al., Characterization of acute promyelocytic leukemia cases lacking the classict(15;17): results of the European Working Party, BLOOD, 96(4), 2000, pp. 1297-1308
The pathogenesis of acute promyelocytic leukaemia: Evaluation of the role of molecular diagnosis and monitoring in the management of the disease
Authors: Grimwade, D
Citation: D. Grimwade, The pathogenesis of acute promyelocytic leukaemia: Evaluation of the role of molecular diagnosis and monitoring in the management of the disease, BR J HAEM, 106(3), 1999, pp. 591-613
Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RAR alpha rearrangement in newly diagnosed AML
Authors: Allford, S Grimwade, D Langabeer, S Duprez, E Saurin, A Chatters, S Walker, H Roberts, P Rogers, J Bain, B Patterson, K McKernan, A Freemont, P Solomon, E Burnett, A Goldstone, A Linch, D
Citation: S. Allford et al., Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RAR alpha rearrangement in newly diagnosed AML, BR J HAEM, 105(1), 1999, pp. 198-207
Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: Result of the randomized MRC trial
Authors: Burnett, AK Grimwade, D Solomon, E Wheatley, K Goldstone, AH
Citation: Ak. Burnett et al., Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: Result of the randomized MRC trial, BLOOD, 93(12), 1999, pp. 4131-4143
Risultati: 1-13 |